.svg)
Discover the gender gap in IBS, uncover why people with celiac disease have a significantly higher risk of developing IBS, and learn more about why people living with IBS and fibromyalgia have elevated rates of severe Multiple Drug Intolerance Syndrome (MDIS). Read on for the March research round-up
Unlocking the gender gap in IBS
A new study dove into the intricate relationship between IBS and gender disparities, particularly among women. The researchers investigated the gut-brain axis, gut dysbiosis, and intestinal permeability and unveiled unique physiological nuances that could hold the key to tailored interventions.
Increased IBS risk for celiacs
Through a 15-year study, celiac disease patients were proven to face a significantly higher risk of developing IBS compared to the general population. Over an average 11.1-year follow-up, 2.7% of celiac patients were diagnosed with IBS, compared to 0.9% of the general population, highlighting the importance of recognizing and managing these long-term associations in your practice.
Severe MDIS rates found in fibromyalgia and IBS patients
New research investigated Multiple Drug Intolerance Syndrome (MDIS) in fibromyalgia and IBS patients, revealing elevated rates of severe MDIS. Notably, IBS patients often reported gastrointestinal symptoms as adverse reactions. Recognizing these conditions during drug allergy evaluations further underscores the need for personalized therapeutic strategies in patients with MDIS and multiple comorbidities.
Discover Mindset Health research.
